This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Study found that alpelisib treated mice had a 10% longer median lifespan than those in the control group[edit]
This is a single study & a primary source, therefore it does not meet WP:MEDRS criteria for inclusion into this article. However, going forward, please look for reviews or surveys of the literature that may discuss this. This article is available through the Wikipedia Library.
Hedges, C. P.; Shetty, B.; Broome, S. C.; MacRae, C.; Koutsifeli, P.; Buckels, E. J.; MacIndoe, C.; Boix, J.; Tsiloulis, T.; Matthews, B. G.; Sinha, S.; Arendse, M.; Jaiswal, J. K.; Mellor, K. M.; Hickey, A. J. R.; Shepherd, P. R.; Merry, T. L. (2023-01-23). "Dietary supplementation of clinically utilized PI3K p110α inhibitor extends the lifespan of male and female mice". Nature Aging. Springer Science and Business Media LLC. doi:10.1038/s43587-022-00349-y. ISSN2662-8465.